Expert Opinion on Drug Delivery (1742-5247; 1744-7593) is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles in drug delivery.

Articles cover all aspects of drug delivery research, from initial concept to potential therapeutic application and final relevance in clinical use. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.

The journal welcomes:

    Reviews covering delivery technologies, vehicles and devices; nanotechnology; novel formulations; the delivery of specific drug and therapeutic classes; gene/vaccine delivery strategies; modes of entry into the body and applications in certain diseases and disorders
    Technology evaluations reviewing a particular drug delivery technology
    Original research contributions are welcomed in the form of:
    - Delivery technologies, vehicles, formulations and devices;
    - The delivery of specific drugs and therapeutic classes;
    - Modes of entry into the body and applications in certain diseases and disorders.

    Editorials commenting on the various drug delivery strategies which have been, and are being, explored
    Guidelines on the application of specific drug delivery systems, or in specific disease indications.


The audience for the journal consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and others closely involved in the delivery of drugs and other therapeutic agents.

Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections:

Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results;

Article Highlights – an executive summary of the author’s most critical points.

Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees. Publish in 3 weeks from submission with Accelerated Publication.

Reach an international clinical and medical audience alongside other key option leaders in your field by publishing with Expert Opinion on Drug Delivery, part of the Expert Collection brand.

EDITOR IN CHIEF
Uday Kompella: University of Colorado, CO, USA
 
EDITORIAL ADVISORY BOARD
Mansoor Amiji: Northeastern University, Boston, MA, USA
Nicholas Bodor: University of Florida, Gainesville, FL, USA
Pieter R Cullis: University of British Columbia, Vancouver, Canada
Elias Fattal: University of Paris - South, Paris, France
Warren Finlay: University of Alberta, Alberta, Edmonton, Canada
Hideyoshi Harashima: Hokkaido University, Hokkaido, Japan
Yogeshvar Kalia: University of Geneva, Geneva, Switzerland
Robert Langer: Massachusetts Institute of Technology, Cambridge, USA
Ram I Mahato: University of Nebraska, USA
Ashim Mitra: University of Missouri, Kansas City, MO, USA
Pankaj Modi: Generex Biotechnology Corporation, Canada
Ravin Narain: University of Alberta, Canada
Seshadri Neervannan: Allergan Inc, USA
Steve Newman: Scientific Consultant, Nottingham, England, UK
Abdel Omri: Laurentian University, Sudbury, Ontario, Canada
Nicholas Peppas: University of Texas, Austin, TX, USA
Michael A Repka: University of Mississippi, MS, USA
Christopher Rhodes: Amylin Pharmaceuticals Inc., San Diego, CA, USA
Abraham Rubinstein: Hebrew University of Jerusalem, Jerusalem, Israel
Bruno Sarmento: University of Porto, Portugal
Alan Smith: Altea therapeutics, Atlanta, GA, USA
Thomas Tice: Evonik Degussa Corporation, Birmingham, AL, USA
Vladimir Torchilin: Northeastern University, Boston, MA
Neeraj Vij: John Hopkins University, Baltimore, USA